One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Public ClinicalTrials.gov record NCT02240121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional, One Year Study to Assess the Efficacy and Safety of Twice Daily Oral Rifaximin Delayed Release Tablets for Induction of Clinical Remission With Endoscopic Response at 16 Weeks Followed by Clinical and Endoscopic Remission at 52 Weeks in Subjects With Active Moderate Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to determine the efficacy of rifaximin DR also referred to as Extended Intestinal Release (EIR) tablets vs. placebo for the induction of clinical remission and endoscopic response following 16 weeks of treatment in participants presenting with active moderate Crohn's disease. A key secondary objective is to evaluate clinical and endoscopic remission following an additional 36 weeks of treatment.
Study identification
- NCT ID
- NCT02240121
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 21, 2014 (Actual)
- Primary completion
- Aug 16, 2017 (Actual)
- Completion
- Aug 16, 2017 (Actual)
- Last update posted
- Sep 10, 2019
2014 – 2017
United States locations
- U.S. sites
- 72
- U.S. states
- 31
- U.S. cities
- 68
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Scottsdale | Arizona | 85260 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Tucson | Arizona | 85724 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Little Rock | Arkansas | 72211 | — |
| Not listed | North Little Rock | Arkansas | 72117 | — |
| Not listed | Bakersfield | California | 93301 | — |
| Not listed | Los Angeles | California | 90067 | — |
| Not listed | Mission Hills | California | 91345 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | San Carlos | California | 94070 | — |
| Not listed | Torrance | California | 90503 | — |
| Not listed | Denver | Colorado | 80045 | — |
| Not listed | Bristol | Connecticut | 06010 | — |
| Not listed | Danbury | Connecticut | 06810 | — |
| Not listed | Boynton Beach | Florida | 33426 | — |
| Not listed | Coral Springs | Florida | 33071 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Homestead | Florida | 33030 | — |
| Not listed | Largo | Florida | 33777 | — |
| Not listed | Miami | Florida | 33165 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Orlando | Florida | 32825 | — |
| Not listed | Plant City | Florida | 33563 | — |
| Not listed | Winter Haven | Florida | 33880 | — |
| Not listed | Winter Park | Florida | 32789 | — |
| Not listed | Atlanta | Georgia | 30342 | — |
| Not listed | Columbus | Georgia | 31909 | — |
| Not listed | Urbana | Illinois | 61801 | — |
| Not listed | Evansville | Indiana | 47714 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Pratt | Kansas | 67124 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Chevy Chase | Maryland | 20815 | — |
| Not listed | Towson | Maryland | 21204 | — |
| Not listed | Marlborough | Massachusetts | 01752 | — |
| Not listed | Ann Arbor | Michigan | 48109 | — |
| Not listed | Chesterfield | Michigan | 48047 | — |
| Not listed | Troy | Michigan | 48098 | — |
| Not listed | Jackson | Mississippi | 39202 | — |
| Not listed | Mexico | Missouri | 65265 | — |
| Not listed | Reno | Nevada | 89511 | — |
| Not listed | Marlton | New Jersey | 08053 | — |
| Not listed | Teaneck | New Jersey | 07666 | — |
| Not listed | Brooklyn | New York | 11235 | — |
| Not listed | Flushing | New York | 11355 | — |
| Not listed | Great Neck | New York | 11021 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | Poughkeepsie | New York | 12601 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Jacksonville | North Carolina | 28546 | — |
| Not listed | Kinston | North Carolina | 28501 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Salisbury | North Carolina | 28144 | — |
| Not listed | Mentor | Ohio | 44060 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Sayre | Pennsylvania | 18840 | — |
| Not listed | Charleston | South Carolina | 29406 | — |
| Not listed | Greenville | South Carolina | 29615 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
| Not listed | Sioux Falls | South Dakota | 57108 | — |
| Not listed | Kingsport | Tennessee | 37660 | — |
| Not listed | Nashville | Tennessee | 37211 | — |
| Not listed | Arlington | Texas | 76012 | — |
| Not listed | Fort Worth | Texas | 76104 | — |
| Not listed | Pasadena | Texas | 77505 | — |
| Not listed | Southlake | Texas | 76092 | — |
| Not listed | Clinton | Utah | 84015 | — |
| Not listed | Leesburg | Virginia | 20176 | — |
| Not listed | Bellevue | Washington | 98004 | — |
| Not listed | Madison | Wisconsin | 53705-2281 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02240121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02240121 live on ClinicalTrials.gov.